Computational design of prefusion-stabilized Herpesvirus gB trimers
relieves scalp redness, itching, oil imbalance, and dandruff troubles
Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor) Disease area(s): Respiratory/rare disease Manufacturer(s): Vertex Pharmaceuticals Incorporated 2024 Sales (USD): $10.24 billion Why it sold so well: Trikafta (marketed as Kaftrio outside the US), a combination therapy of elexacaftor, tezacaftor and ivacaftor, was the primary driver of Vertex Pharmaceuticals strong commercial performance in 2024
The ability to go extended periods without hunger or eating, while pharmacologically useful for weight loss, can reinforce dangerous behaviors in vulnerable individuals
Magn Reson Imaging 28:163170 Stewart VC, Stone R, Gegg ME, Sharpe MA, Hurst RD, Clark JB, Heales SJ (2002) Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase